Massachusetts Medical Cannabis Center
AmeriCann has secured the option to purchase a 52 acre parcel of land located in Southeastern Massachusetts. The property, located in a Medical Marijuana Overlay district, is being designed and permitted to create a center of excellence for the cannabis industry serving medical patients in Massachusetts.
The Company plans to develop the property as the Massachusetts Medical Cannabis Center “MMCC”. Plans for the MMCC include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program. Additional plans for the MMCC include a testing laboratory, a research facility, a training center and corporate offices.
The design of the MMCC development will set a new cannabis industry standard for energy efficiency, cost control, clean cultivation practices, and the production of Neutraceutical-grade infused products for the patients of Massachusetts.
Each RMD operation will be designed to be 100% self-sufficient to comply with the regulations set forth by the Department of Public Health. All RMDs will have internal security protocols and equipment, all regulated material will be secured within each RMDs secured access areas. The development program for the park will include:
• Two self-contained, energy efficient cultivation and processing centers utilizing state-of-the-art greenhouse technology.
• Independent cannabis testing laboratory
• Corporate offices and leased office space for ancillary cannabis tenants
• 24 hour security
• On-site regulated waste disposal for tenants
• Secure shipping and transportation infrastructure
The MMCC has the potential to emerge as the leading cannabis facility in the world and set the standard for cultivation facilities of the future. AmeriCann is finalizing designs and permitting and construction may start by the first quarter of 2016.